Search Results

Cosmos Health Inc. announced the successful acquisition of the distribution network owned by Pharmatrade S.A., an established pharmaceutical wholesale company operating in Greece.

Medtronic plc, a global leader in healthcare technology, announces that it has entered into a definitive agreement to expand its partnership with Cosmo Intelligent Medical Devices, a subsidiary of Cosmo Pharmaceuticals.

Cosmos Health Inc. (“Cosmos Health” or the “Company’’) (NASDAQ:COSM) announced today that it has entered into a definitive agreement, subject to customary closing conditions, with a related party to acquire the license and rights for “DIABIT-IS X”, a drug used in the treatment of type-2 diabetes.

Cosmos Health Inc. provided a business update highlighting the expected revenue growth resulting from the various companies and assets it acquired within 2023, as well as a forecast for revenue, gross profit, and EBITDA in the upcoming year, exclusively attributed to these acquisitions.

Cosmos Health Inc. announced an agreement with Cloudpharm PC to acquire the rights arising from the patent filed with the World Intellectual Property Organization, under reference code PCT/EP2023/071865.

Tonix Pharmaceuticals Holding Corp. announced today that Seth Lederman, M.D., Chief Executive Officer, will participate virtually in a fireside chat at A.G.P.’s Healthcare Company Showcase on Tuesday, May 21, 2024, at 9:00 a.m. ET.

Hyphens Pharma International Limited is pleased to announce that its subsidiary, Hyphens Pharma Pte. Ltd., has entered into exclusive license and supply agreements with Cassiopea S.p.A., a subsidiary of Cosmo Pharmaceuticals N.V. for the exclusive rights to develop and commercialize Winlevi® cream 1% and all future product extension and/or improvement in the treatment of acne in 10 countries across Southeast Asia.

Enanta Pharmaceuticals, Inc., a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications, announced the appointment of Matthew P. Kowalsky, J.D., as Chief Legal Officer.

Donaldson Company, Inc., a leading worldwide provider of innovative filtration products and solutions, announced it has entered into a definitive agreement allowing the Company to purchase a 49% stake in Medica S.p.A.